By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Obesity Treatment Moving Toward Fragmented Clinical Approaches
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Obesity Treatment Moving Toward Fragmented Clinical Approaches
BusinessMedical DevicesNewsPublic Health

Obesity Treatment Moving Toward Fragmented Clinical Approaches

PatrickDriscoll
PatrickDriscoll
Share
2 Min Read
SHARE

The obesity market is on the verge of new product introductions (especially drugs) and will soon become more fragmented by treatment options and competitors.  The FDA has relented in the drug front, making it likely in the next 1-2 years (as we predicted) that the market will be split among appetite suppression, malabsorption, satiey and combination drugs.  The trend is equally strong in the device arena, where the market dominance of restrictive devices (e.g., Lap-Band) will cede to artificial fullness, malabsorption, gastric emptying, and appetite suppression devices.

The obesity market is on the verge of new product introductions (especially drugs) and will soon become more fragmented by treatment options and competitors.  The FDA has relented in the drug front, making it likely in the next 1-2 years (as we predicted) that the market will be split among appetite suppression, malabsorption, satiey and combination drugs.  The trend is equally strong in the device arena, where the market dominance of restrictive devices (e.g., Lap-Band) will cede to artificial fullness, malabsorption, gastric emptying, and appetite suppression devices.

Below is illustrated the balance of the drug and device markets by type of obesity product.

 

More Read

How to Use Instagram Video in Healthcare
Bundled Payments for Care Improvement Initiative Announced by CMS Center for Innovation
3 Pathology Synoptic Reporting Examples
Getting Healthcare on the EB-5 Immigrant Investor Program
Creating an effective care plan: The ultimate guide

Balance of Obesity Drugs and Device Markets by Type 2009-2019

Source: “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019″, Report #S835, MedMarket Diligence, LLC.

 

Of course, another way to view the obesity market that is supported by the general trend of clinical treatment options competing against each other irrespective of technology type is that the aggregate obesity market is comprised of a shifting balance among device and drug options.  In any case, below is illustrated the relative balance of all drug and device markets for the treatment of obesity.

Balance of All Obesity Drugs and Device Markets by Type 2009-2019

Source: “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019″, Report #S835, MedMarket Diligence, LLC.

     

TAGGED:obesity
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

How Setting Boundaries Helps Trauma Survivors Heal
Health
October 30, 2025
how to improve REM sleep
Unlock Better Sleep: How to Improve REM Sleep Naturally
Wellness
October 30, 2025
uv protection in winter
Winter Sun Safety: Why UV Protection Matters Year-Round
Health
October 29, 2025
Nurse Scheduling Software
Evaluating 7 Best Nurse Scheduling Software
Nursing Technology
October 28, 2025

You Might also Like

Clinical-Trial-Marketing-Wearable-Technology-Healthcare
BusinessGlobal HealthcareMedical DevicesMedical InnovationsTechnology

Are Wearables the Future of Clinical Trials?

June 24, 2015
digital-analytics-101-blogging
BusinesseHealthSocial Media

Digital Analytics 101 for Healthcare Marketers: Blogging

March 10, 2016

Cut-Rate Concierge Medicine? One Medical Resorts to Discounting

February 4, 2014

Why Pilot Projects Don’t Work

January 4, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?